Analysts think VYGR stock price could increase by 182%
Dec 26, 2024, 12:25 PM
-2.60%
What does VYGR do
Voyager Therapeutics, a clinical-stage gene therapy company based in Lexington, Massachusetts, focuses on developing treatments for severe neurological diseases, including Alzheimer's and ALS. Founded in 2015, it employs 162 people and utilizes its TRACER AAV platform for therapy development.
12 analysts think VYGR stock price will increase by 182.35%. The current median analyst target is $16.32 compared to a current stock price of $5.78. The lowest analysts target is $11.11 and the highest analyst target is $31.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.